Home › Triple-Negative Breast Cancer › Utah › West Valley City
Pag-aaral pangklinika para sa Triple-Negative Breast Cancer sa West Valley City, UT
Isang pag-aaral para sa Triple-Negative Breast Cancer ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa West Valley City. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
Nagre-recruitPhase 1
- START Mountain Region, West Valley City
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
Nagre-recruitPhase 1
- START Mountain Region, West Valley City
A Study of Sofe-M in Participants With Selected Advanced Solid Tumors
Nagre-recruitPhase 1
- START Mountain Region, West Valley City
A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors
Nagre-recruitPhase 1
- South Texas Accelerated Research Therapeutics (START) Mountain Region, West Valley City
Study to Assess GTAEXS617 in Participants With Advanced Solid Tumors
Nagre-recruitPhase 1/2
- START Mountain Region, West Valley City
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
Nagre-recruitPhase 1/2
- START Mountain Region, West Valley City
A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
Nagre-recruitPhase 1
- START Mountain Region, West Valley City
A Study to Learn About the Study Medicine Called PF-08032562 in People With Advanced or Metastatic Solid Tumors
Nagre-recruitPhase 1
- START Mountain Region, West Valley City
A Study of LY4175408 in Participants With Advanced Cancer
Nagre-recruitPhase 1
- START Mountain Region, West Valley City
Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan
Nagre-recruitPhase 1
- Start Mountain Region /ID# 276270, West Valley City
A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types
Nagre-recruitPhase 1
- START Mountain Region, LLC, West Valley City
Dose Determining Study of EXS74539 (REC-4539) in Participants With Select Solid Tumors
Nagre-recruitPhase 1
- START Mountain Region, West Valley City
PQ203 in Advanced Malignant Tumors Including Triple Negative Breast Cancer
Nagre-recruitPhase 1
- START Mountain Region, West Valley City
Pag-aaral para sa Triple-Negative Breast Cancer sa ibang lungsod
- Houston, TX42 pag-aaral
- New York City, NY31 pag-aaral
- Nashville, TN28 pag-aaral
- Los Angeles, CA27 pag-aaral
- Boston, MA26 pag-aaral
- San Antonio, TX23 pag-aaral
- St. Louis, MO21 pag-aaral
- Arlington, VA20 pag-aaral
- Atlanta, GA20 pag-aaral
- Dallas, TX18 pag-aaral
- Chicago, IL16 pag-aaral
- Columbus, OH16 pag-aaral
Iba pang pag-aaral sa West Valley City
- Non-Small Cell Lung Cancer25 pag-aaral
- Colorectal Cancer17 pag-aaral
- Kanser sa Suso13 pag-aaral
- Metastatic Cancer13 pag-aaral
- Kanser sa Pancreas12 pag-aaral
- Kanser (lahat ng uri)11 pag-aaral
- Kanser sa Ovary11 pag-aaral
- Squamous Cell Carcinoma ng Ulo at Leeg11 pag-aaral
- Kanser ng Endometrium10 pag-aaral
- Kanser sa Tiyan8 pag-aaral
- Squamous Cell Carcinoma ng Esophagus7 pag-aaral
- Small Cell Lung Cancer7 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.